PAVM

PAVmed Inc.

1.88 USD
-0.01 (-0.53%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

PAVmed Inc. stock is down -18.26% since 30 days ago. The next earnings date is Mar 12, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a red month, as 25% of the previous 7 February’s closed higher than January.

About PAVmed Inc.

PAVmed Inc. operates as a medical device company in the United States. The company's lead products include CarpX, a percutaneous device to treat carpal tunnel syndrome; and EsoCheck, an esophageal cell collection device for the early detection of adenocarcinoma of the esophagus and Barrett's Esophagus (BE)